Research Triangle Park, NC, United States of America

Jason Gordon Weatherhead

USPTO Granted Patents = 16 (Patent Applications = 10)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 41(Granted Patents)

Location History:

Durham, NC (US) (2014)
Research Triangle Park, NC (US) (2012 - 2019)

Company Filing History:

10 out of 1,001

Shionogi Company Limited

patents

9 out of 40

Viiv Healthcare Company

patents

4 out of 9

Viiv Healthcare UK Limited

Glaxosmithkline Intellectual Property Development Limited

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12221444 - 5,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one compounds and methods of use (2025-02-11),

2. 10239840 - Benzoazepine derivatives (2019-03-26),

3. 10118894 - Isoindolinone derivatives useful as antiviral agents (2018-11-06),

4. 10112899 - Isoindoline derivatives for use in the treatment of a viral infection (2018-10-30),

5. 9707246 - Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agents (2017-07-18),

6. 9163023 - Compounds and methods for treating HIV (2015-10-20),

7. 9133216 - (3S,11aR)-6-[(phenylmethyl)oxy]-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-9 and/or (3S,11aR)-6-[(phenymethyl)oxy]-8-bromo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-dione of the formula P-10 (2015-09-15),

8. 9012650 - Substituted (3S, 11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides of formula (I) useful as HIV agents (2015-04-21),

9. 8981129 - 2-(2-hydroxy-2-phenylethyl)-3-[(phenylmethyl)oxy]-4H-pyran-4-one of the formula P-3 and/or 2-[(E)-2-phenylethenyl]-3-[(phenylmethyl)oxy]-4H-Pyran-4-one of the formula P-4 (2015-03-17),

10. 8940912 - 4-oxo-3-[(phenylmethyl)oxy]-4H-pyran-2-carboxylic acid (2015-01-27),

11. 8765965 - 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic acid of the formula P-6 and/or methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate of the formula P-7 (2014-07-01),

12. 8691991 - 2-oxonaphthyridine-3-carboxamides HIV integrase inhibitors (2014-04-08),

13. 8691823 - Prodrugs of (4aS, 13ar)-N-[(2,4-difluorophenyl)methyl]-10-hydroxy-9-11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1H-pyrido[1,2-a]pyrrolo[1',2′:3:4]imidazo[1,2-d]pyrazine-8-carboxamide and their use in the treatment of HIV infection (2014-04-08),

14. 8609653 - Azaindole compounds and methods for treating HIV (2013-12-17),

15. 8580967 - Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereof (2013-11-12),

Title: Innovator Spotlight: Jason Gordon Weatherhead

Introduction: Jason Gordon Weatherhead, a prolific inventor based in Research Triangle Park, NC, has made significant contributions to the field of antiviral agents. With an impressive portfolio of 15 patents, he continues to push the boundaries of innovation in combating viral infections.

Latest Patents: Weatherhead's recent patents showcase his expertise in developing novel compounds for treating viral infections. His inventions include Benzoazepine derivatives and Isoindolinone derivatives, both of which have shown promise in effectively combating viral illnesses.

Career Highlights: Weatherhead has honed his skills while working at esteemed companies such as Shionogi & Company Limited and ViiV Healthcare. His experience in these organizations has undoubtedly fueled his passion for creating groundbreaking solutions in the realm of antiviral medications.

Collaborations: Throughout his career, Weatherhead has collaborated with industry experts including Brian Alvin Johns and Yasunori Aoyama. These partnerships have not only enriched his projects but have also paved the way for innovative breakthroughs in antiviral research.

Conclusion: Jason Gordon Weatherhead's dedication to innovation and his unwavering commitment to advancing antiviral therapeutics have established him as a notable figure in the scientific community. His impressive patent portfolio is a testament to his ingenuity and relentless pursuit of finding solutions to combat viral infections, making him a true pioneer in the field.

This text is generated by artificial intelligence and may not be accurate.